Home / Market News / $TWST
benzinga Corporate Catalyst Impact 75/100 ● positive

Twist Bioscience shares are trading higher after Guggenheim raised its price target on the stock from $107 to $212.

Oct 1, 2026, 3:34 PM UTC · Primary ticker $TWST

Twist Bioscience (TWST) shares are experiencing a significant positive movement due to a substantial price target increase from Guggenheim. This analyst upgrade signals strong confidence in the company's future prospects and valuation, likely attracting increased investor interest.

This headline indicates a strong positive catalyst for Twist Bioscience. A near-doubling of a price target by a reputable firm like Guggenheim suggests a re-evaluation of the company's intrinsic value, potentially driven by new product developments, market penetration, or improved financial outlook. The immediate impact is a surge in TWST's stock price, reflecting increased investor confidence and demand. Key risks include the possibility of the upgrade being overly optimistic or the company failing to meet future expectations. This event primarily affects the biotechnology sector, particularly companies involved in synthetic DNA and genomics, as it highlights investor appetite for innovation in this space. Trading implications include potential for continued upward momentum in TWST, but also a need for investors to assess the fundamental basis for the upgrade.

$TWST positive Significant price target increase
Source: benzinga
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.